Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Quetiapine
Cat. No.:
OB0225LY-0107
Appearance:
Oil
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Quetiapine is an atypical antipsychotic that inhibits the histamine H1 receptor.
Synonym:
Quetiapin; 111974-69-7; 2-[2-(4-Benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol; Quetiapine extended release; 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol; 2-{[2-(4-Dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol; (E)-2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol
CAS No.:
111974-69-7
Compound CID:
5002
Formula:
C21H25N3O2S
Formula Weight:
383.51
Specification
Relative Density:
1.205 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Quetiapine plays a role in schizophrenia, bipolar disorder and major depression research and drug development.
Library Information
Targets:
Dopamine receptor; 5-HT receptor; Adrenergic receptor; AChR; Histamine receptor
Receptors:
H1 receptor; mAChR; D2 receptor; 5-HT2A receptor; 5-HT2C receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
c10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 117.34 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
